Delcath Systems (DCTH) Stock: Buy, Sell, or Hold?
DCTH - Delcath Systems Inc
$14.51
0.09 (0.62%)
▲
5d:
+0.97%
30d:
-6.99%
90d:
+25.63%
HOLD
MODERATE Confidence
Analysis Updated: Oct 26, 2026 12:00 AM ET
Earnings: Nov 03, 2026
6d
Get Alerted When DCTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DCTH trades at premium valuation expecting 19.9% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: DCTH trades at premium valuation expecting 19.9% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: DCTH is currently trading at $14.51, which is considered oversold relative to its 30-day fair value range of $14.69 to $15.94. From a valuation perspective, the stock is trading at a premium (Forward PE: 322.4) compared to its historical average (186.9). At these levels, the market is pricing in 19.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DCTH is in a strong uptrend. Immediate support is located at $14.00, while resistance sits at $15.77.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $24.00 (+65.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DCTH is in a strong uptrend. Immediate support is located at $14.00, while resistance sits at $15.77.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $24.00 (+65.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.69 -
$15.94
Company Quality Score
61/100
(BUY)
Options IV Signal
45th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
76.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 45th percentile)
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 65.4% below Wall St target ($24.00)
- NEUTRAL: Trading at premium valuation - market expects 19.9% growth which is achievable
- NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$14.69 -
$15.94
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.74
(12.0%)
Support & Resistance Levels
Support Level
$14.00
Resistance Level
$15.77
Current Trend
Strong Uptrend
Technical data as of
Oct 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
322.44
Wall Street Target
$24.00
(+65.4%)
Revenue Growth (YoY)
20.6%
Profit Margin
0.6%
Valuation Premium vs History
+19.9% premium
PE vs Historical
322.4 vs 186.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+19.9%
(market-implied from PE analysis)
1-Year Target
$17.40
(+20%)
2-Year Target
$20.86
(+44%)
3-Year Target
$25.01
(+72%)
3-Yr Target (if PE normalizes)
(PE: 322→187)
PE COMPRESSION
$14.50
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: October 27, 2026 8:44 AM ET
Data refreshes hourly during market hours. Next update: 9:44 AM
Data refreshes hourly during market hours. Next update: 9:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
30 analysts |
$58 | 54 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 52 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 35 SELL |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
16 analysts |
$171 | 50 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
11 analysts |
$53 | 66 BUY |
